South Korea · Delayed Price · Currency is KRW Hanall Biopharma Company Description
Hanall Biopharma Co., Ltd., a pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
The company offers prescription drugs and over-the-counter products for the treatment of diarrhea, prostatic hyperplasia, androgenetic alopecia, chronic renal failure, hypoparathyroidism, vitamin D-resistant rickets, osteomalacia, osteoporosis, prostate cancer, toxic liver disease, chronic hepatitis, liver cirrhosis, male pattern baldness, functional dyspepsia, diabetes, bacterial infections, peripheral vascular disorders, hypertension, chronic heart failure, skin diseases, hypoproteinemia, diabetic polyneuritis, ulcers, high blood pressure, arthritis, endocrine disorders, spasms, insomnia, muscle pain, hypoproteinemia, gastroesophageal reflux disease, allergic rhinitis, conjunctivitis, dermatitis, chronic urticaria, cholesterol cholelithiasis, gastritis, neurological diseases, erectile dysfunction, hyperphosphatemia, urinary tract infection, spastic paralysis, fungal infections, dysmenorrhea, hypercholesterolemia, constipation, abdominal distension, abdominal fermentation in the intestines, neuralgia, capillary weakness, post-phlebitis syndrome, irritable bowel syndrome, spastic colon, and hemorrhoids, as well as vitamin D, vitamin B1, vitamin B12, and calcium deficiency.
It develops products in the fields of ophthalmology, immunology, oncology, and neurology, such as HL192 for Parkinson’s disease; HL036 for dry eye disease; HL161 for myasthenia gravis, thyroid eye disease, warm autoimmune hemolytic anemia, neuromyelitis optica, immune thrombocytopenia, chronic inflammatory demyelinating polyneuropathy, and graves’ disease; and HL187 and HL186 for immuno-oncology.
The company was founded in 1973 and is headquartered in Daejeon, South Korea.
| Country | South Korea |
| Founded | 1973 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 304 |
Contact Details
Address: 43, Sangseodang 1-gil Daejeon South Korea | |
| Phone | 82 42 932 5997 |
| Website | hanall.co.kr |
Stock Details
| Ticker Symbol | 009420 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7009420001 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Su-Jin Park | Co-Chief Executive Officer, Vice President and Director |
| Sean Jeong | President, Co-Chief Executive Officer and Director |
| Christopher W. Slavinsky | Chief Business Development and Legal Officer |
| Nam-Yong Cho | Senior Executive Director of Sales and Marketing and Senior Managing Director |
| Jae-Seung Yoon | C.V.O |
| Hye Kyung Ahn | Head of Research Division |
| SeongUn Kim | Head of Business Management Division |